Pigeon HMMR/CD168 ELISA Kit – Cat# MBS079925

Hyaluronan-Mediated Motility Receptor (HMMR/CD168) ELISA Kit for Pigeon

Name: Pigeon HMMR/CD168 ELISA Kit; Hyaluronan-Mediated Motility Receptor; MyBioSource
Brand: MyBioSource
SKU: MBS079925
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS079925

MBS079925 is a ready-to-use microwell, strip-or-full plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the Hyaluronan-Mediated Motility Receptor (HMMR/CD168) ELISA Kit target analytes in biological samples. The concentration… More details

Please Inquire

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Request Current Manual

Product Overview

Online Datasheet in PDF

Product Name

Hyaluronan-Mediated Motility Receptor (HMMR/CD168), ELISA Kit

Full Product Name

Pigeon Hyaluronan-Mediated Motility Receptor ELISA Kit

Product Gene Name

HMMR/CD168 elisa kit

Species Reactivity

Pigeon

Preparation and Storage

Store all reagents at 2-8 degree C

Molecular Weight

84,100 Da

Chromosome Location

Chromosome: 5; NC_000005.9 (162887517..162918951). Location: 5q33.2-qter

OMIM

600936

3D Structure

ModBase 3D Structure for O75330

Other Notes

Small volumes of HMMR/CD168 elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for HMMR/CD168. It may not necessarily be applicable to this product.

NCBI GI #

217416398

NCBI GeneID

3161

NCBI Accession #

NP_036617.2

UniProt Primary Accession #

O75330

UniProt Secondary Accession #

Q32N02; Q92767; A8K3G2; B4E114; D3DQK9; D3DQL0; E9PCS0

UniProt Related Accession #

O75330

GenBank Nucleotide #

NM_012485.2

NCBI Official Full Name

hyaluronan mediated motility receptor isoform c

NCBI Official Synonym Full Names

hyaluronan-mediated motility receptor (RHAMM)

NCBI Official Symbol

HMMR

NCBI Official Synonym Symbols

CD168; IHABP; RHAMM

UniProt Protein Name

Hyaluronan mediated motility receptor

UniProt Synonym Protein Names

Intracellular hyaluronic acid-binding protein; Receptor for hyaluronan-mediated motility

Protein Family

Hyaluronan mediated motility receptor

UniProt Gene Name

HMMR

UniProt Synonym Gene Names

IHABP; RHAMM

UniProt Entry Name

HMMR_HUMAN

NCBI Protein Information

hyaluronan mediated motility receptor; receptor for hyaluronan-mediated motility; intracellular hyaluronic acid-binding protein

NCBI Summary for HMMR/CD168

The protein encoded by this gene is involved in cell motility. It is expressed in breast tissue and together with other proteins, it forms a complex with BRCA1 and BRCA2, thus is potentially associated with higher risk of breast cancer. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Dec 2008]

UniProt Comments for HMMR/CD168

HMMR: Involved in cell motility. When hyaluronan binds to HMMR, the phosphorylation of a number of proteins, including PTK2/FAK1 occurs. May also be involved in cellular transformation and metastasis formation, and in regulating extracellular- regulated kinase (ERK) activity. 4 isoforms of the human protein are produced by alternative splicing.

Protein type: Receptor, misc.

Chromosomal Location of Human Ortholog: 5q34

Cellular Component: cell surface; membrane; cytoplasm; plasma membrane

Molecular Function: hyaluronic acid binding

Biological Process: glycosaminoglycan metabolic process; carbohydrate metabolic process; pathogenesis; hyaluronan metabolic process; hyaluronan catabolic process

Disease: Breast Cancer

Research Articles on HMMR/CD168

1. RHAMM does not fulfill the criteria of an ideal target antigen for immunotherapy of acute myeloid leukemia.

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with HMMR/CD168 elisa kit

Reference Product	PubMed Publications
CD44 elisa kit	>17 publications with HMMR/CD168 and CD44
AURKA elisa kit	>3 publications with HMMR/CD168 and AURKA
TPX2 elisa kit	>2 publications with HMMR/CD168 and TPX2
DLGAP5 elisa kit	>1 publications with HMMR/CD168 and DLGAP5
ASPM elisa kit	>1 publications with HMMR/CD168 and ASPM

Pathways associated with HMMR/CD168 elisa kit

Products by Pathway	Pathway Diagram
Disease Pathway antibodies	Disease Pathway Diagram
ECM-receptor Interaction Pathway antibodies	ECM-receptor Interaction Pathway Diagram
ECM-receptor Interaction Pathway antibodies	ECM-receptor Interaction Pathway Diagram
Glycosaminoglycan Metabolism Pathway antibodies	Glycosaminoglycan Metabolism Pathway Diagram
Hyaluronan Metabolism Pathway antibodies	Hyaluronan Metabolism Pathway Diagram
Hyaluronan Uptake And Degradation Pathway antibodies	Hyaluronan Uptake And Degradation Pathway Diagram
MPS I - Hurler Syndrome Pathway antibodies	MPS I - Hurler Syndrome Pathway Diagram
MPS II - Hunter Syndrome Pathway antibodies	MPS II - Hunter Syndrome Pathway Diagram
MPS IIIA - Sanfilippo Syndrome A Pathway antibodies	MPS IIIA - Sanfilippo Syndrome A Pathway Diagram
MPS IIIB - Sanfilippo Syndrome B Pathway antibodies	MPS IIIB - Sanfilippo Syndrome B Pathway Diagram

Diseases associated with HMMR/CD168 elisa kit

Disease Name	Pubmed Publications
Neoplasms Antibodies	>22 publications with HMMR/CD168 and Neoplasms
Breast Neoplasms Antibodies	>8 publications with HMMR/CD168 and Breast Neoplasms
Adenocarcinoma Antibodies	>5 publications with HMMR/CD168 and Adenocarcinoma
Neoplasms, Experimental Antibodies	>3 publications with HMMR/CD168 and Neoplasms, Experimental
Disease Models, Animal Antibodies	>3 publications with HMMR/CD168 and Disease Models, Animal
Lung Neoplasms Antibodies	>2 publications with HMMR/CD168 and Lung Neoplasms
Inflammation Antibodies	>2 publications with HMMR/CD168 and Inflammation
Nervous System Diseases Antibodies	>2 publications with HMMR/CD168 and Nervous System Diseases
Carcinoma, Squamous Cell Antibodies	>2 publications with HMMR/CD168 and Carcinoma, Squamous Cell
Peripheral Nervous System Diseases Antibodies	>2 publications with HMMR/CD168 and Peripheral Nervous System Diseases

Organs/Tissues associated with HMMR/CD168 elisa kit

Organ/Tissue Name	Pubmed Publications
Blood Antibodies	>6 publications with HMMR/CD168 and Blood
Nerve Antibodies	>4 publications with HMMR/CD168 and Nerve
Lung Antibodies	>3 publications with HMMR/CD168 and Lung
Bone Marrow Antibodies	>3 publications with HMMR/CD168 and Bone Marrow
Vascular Antibodies	>2 publications with HMMR/CD168 and Vascular
Skin Antibodies	>2 publications with HMMR/CD168 and Skin
Salivary Gland Antibodies	>1 publications with HMMR/CD168 and Salivary Gland
Mouth Antibodies	>1 publications with HMMR/CD168 and Mouth
Eye Antibodies	>1 publications with HMMR/CD168 and Eye
Bladder Antibodies	>1 publications with HMMR/CD168 and Bladder